PAHO launches REGIA, a platform to explore and compare clinical trial regulatory requirements across the Americas

REGIA plataforma clinical trials regulations

Washington, D.C., 16 November 2026 - The Pan American Health Organization (PAHO) has launched REGIA (Regulation for Research in the Americas), a unique open-access digital platform that brings together, organizes, and compares regulatory requirements for conducting clinical trials across countries in the Americas. The platform was developed by PAHO’s Regional Program on Bioethics as part of the Clinical Trial Accelerator initiative.

REGIA addresses a common challenge faced by researchers, sponsors and regulatory authorities: information on clinical trial requirements is often dispersed across multiple sources, while regulations vary from country to country, making it difficult to identify and access up-to-date regulatory information.

“REGIA brings together key regulatory information on clinical trials in the Americas in one place, making it easier to access national regulations and official sources while promoting greater transparency and understanding of country-specific regulatory requirements,” said Dr. Carla Saenz, PAHO Regional Advisor on Bioethics.

The platform presents information in a question-and-answer format based on each country's current regulations. Users can explore the regulatory requirements of a specific country, compare information across up to three countries simultaneously, or filter countries according to specific regulatory requirements.

Search and comparison results can be downloaded as PDF documents for future reference and use. Access to REGIA is free of charge and no registration is required.

“By facilitating access to organized and comparable regulatory information, REGIA not only supports the conduct of clinical research across the Region but also helps national authorities better understand international research standards and update their regulations to align with them,” said Dr. Ludovic Reveiz, Chief of the Science and Knowledge for Impact Unit within PAHO’s Department of Evidence and Intelligence for Action in Health.

The platform is intended for researchers, study sponsors, research ethics committees, regulatory authorities and anyone interested in clinical trial regulation in the Americas.

REGIA is part of PAHO's broader efforts to strengthen regional clinical research capacities and support the conduct of clinical trials that are efficient, ethical and aligned with current regulatory standards.

Explore REGIA: https://www.paho.org/en/regia